Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.36B P/E - EPS this Y -48.00% Ern Qtrly Grth -
Income -252.43M Forward P/E -8.38 EPS next Y 40.50% 50D Avg Chg -
Sales 799.6M PEG -0.29 EPS past 5Y - 200D Avg Chg 16.00%
Dividend N/A Price/Book 0.88 EPS next 5Y 12.00% 52W High Chg -36.00%
Recommedations 1.50 Quick Ratio 0.95 Shares Outstanding 696.99M 52W Low Chg 76.00%
Insider Own 52.41% ROA -6.01% Shares Float 330.95M Beta 1.76
Inst Own 23.75% ROE -18.00% Shares Shorted/Prior 85.23M/78.03M Price 1.76
Gross Margin 22.76% Profit Margin -31.57% Avg. Volume 3,801,127 Target Price 4.25
Oper. Margin -41.15% Earnings Date Aug 1 Volume 2,222,674 Change -3.30%
About Opko Health, Inc.

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.

Opko Health, Inc. News
06/06/24 Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report?
06/01/24 Bullish OPKO Health Insiders Loaded Up On US$12.9m Of Stock
05/31/24 OPKO Health to Participate in the Jefferies Global Healthcare Conference
05/31/24 The 2024 Millionaire’s Club: 3 Penny Stocks to Buy Now
05/09/24 OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
05/08/24 OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
05/08/24 Q1 2024 OPKO Health Inc Earnings Call
05/08/24 OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ...
05/07/24 Opko Health (OPK) Q1 2024 Earnings Call Transcript
05/07/24 OPKO Health (OPK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
05/07/24 OPKO Health Inc (OPK) Q1 2024 Earnings: Misses Revenue and Earnings Estimates
05/07/24 OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
05/07/24 OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
05/03/24 OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
04/01/24 OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
04/01/24 Labcorp (LH) to Boost Clinical Diagnostics With New Deal
03/28/24 Labcorp inks $237.5M buyout of Opko’s reproductive, women’s health testing assets
03/28/24 Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
03/25/24 OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
03/20/24 Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
OPK Chatroom

User Image tymtested Posted - 18 hours ago

$OPK I think Frost may have made a mistake spinning off WGS..... good thing he kept a few shares!

User Image tymtested Posted - 1 day ago

$OPK what are the huge volume trades on the absolute last click of the day???

User Image semihound Posted - 1 day ago

$OPK had a big chunk back when every one still thought that Phil was the 2nd coming of JC. Got burned bad on the fall from the teens to penny status. My own fault. DD clearly showed that some of the of the people PF was forming the OPK subsidaries with had questionable backgrounds and where pushing wierd things (for a purported cutting edge bio like OPK) like protein powder drinks. I think they all ended up in consent agreement with the SEC. But early on we all thought PF was going to take us to the moon. We even had our own private message board. I still have 500 shares in the etrade acct that was the scene of the crime. A little bit of Cocrystal pharma in there too. If they still havent had a break through yet, I wouldn't hold my breath.

User Image Brasil07 Posted - 1 day ago

$OPK must die,must die....Frost must die

User Image tymtested Posted - 1 day ago

$OPK QQQ is attracting the majority of investment money currently. everything else is second fiddle or worse. OPKO's day is coming... holding long!!

User Image zaza1 Posted - 1 day ago

$OPK it's funny or not We lose 5% that mean 45 million out of market capacity and the volume is 1.3 million $ It's not real!!!

User Image Zerrat Posted - 2 days ago

$OPK pumping little and dumping hard get it from 10 to 1 and then wut, from 1 to 0.1?

User Image tradertrash Posted - 2 days ago

$OPK this will break out when frosty gets his personality transplant

User Image zaza1 Posted - 2 days ago

$OPK $wgs holding worth for now around 110 mil$ for opko. Shorties hold the share and cover slowly slowly with insurance of notes covering in 1.5$. Until when? Until we get trigger Frosty is old. Everything can happen. Maybe buyout. I think the big institual like Blackrock/vanguard/street ext' Hold a big stake in opko because they see the day after...

User Image Scientwist Posted - 2 days ago

$OPK Its going to break out.. just a matter of when!

User Image tymtested Posted - 2 days ago

$OPK WGS just added another $4 million to OPKO value today!

User Image tymtested Posted - 2 days ago

$OPK somebody just bought 700,000 shares!! I wonder why??

User Image Cooco Posted - 2 days ago

$OPK this might go down below $1 tomorrow. Ugh i feel bad for myself. I shouldve not even invested

User Image momo2021 Posted - 2 days ago

$OPK lock fake jimmy up! He is a puppet. These creeps deserve the chair @Resurrected_Magic @The_Original_Magic = removed by ST for fraud 15k lies 🤣

User Image tradertrash Posted - 2 days ago

$OPK just my opinion and it's worth nothing, these azzholz should pay a dividend to sh for holding this garbage

User Image zaza1 Posted - 3 days ago

$OPK Frosty give us trigger. We want 20$ per share.

User Image tradertrash Posted - 3 days ago

$OPK there broke, and haven't been successful delivering value for sh with anything, acquiring commodeX with there track record for sh??? it's all just to scammy imo

User Image Resurrected_Magic Posted - 3 days ago

$OPK has no money or resources to run the trials, was given the assets basically for free by management knowing at that time Leadermed had no ability to conduct any trials as they disclosed that in the subsequent filings. So here we are in a classic Frost move with 2 potentially big drugs collecting dust while competition moves ahead with commercialization. All by design to destroy the company from within like they have done for decades across dozens of other firms that they ruined and stole billions in the processing https://leadermedgroup.com/pipeline/ Acuity pharma, Arno Therapeutics, Asensus ASXC, Biocardia BCDA, Biozone, Cardo Medical, Chromadex CDXC, Cocrystal COCP, Cogent COGT, Drone Aviation DRNE, Eloxx, Exegenics, Fluent FLNT, Froptix, GeneDx WGS, Levon, Muscle pharma, MabVax MBVX, Noninvasive monitoring systems NIMU, Neovasc NVCN, Opko, OPK, Pulmatrix PULM, Polarityte PTE, Phio Pharmaceuticals, Safestitch, Sevion, SciVac, Teva, Tiger X, Transenterix , VBI vaccines VBIV, Veru VERU, Xenetic XBIO

User Image tymtested Posted - 3 days ago

$OPK opko is selling the loss making business. Existing ongoing earnings streams support a much higher stock price! Opk is highly undervalued!

User Image Resurrected_Magic Posted - 3 days ago

$OPK if OPK88003 worked then pfizer wouldn't need to scout earlier stage assets. https://www.prnewswire.com/news-releases/flagship-pioneering-and-profound-therapeutics-announce-agreement-to-identify-novel-first-in-class-therapeutics-for-the-treatment-of-obesity-under-strategic-partnership-with-pfizer-302170276.html

User Image tradertrash Posted - 4 days ago

$OPK it's up a penny!!! just pissing myself with excitement ffs

User Image Swing_Trader_No_1 Posted - 4 days ago

$OPK Thank you HWS**

User Image bigmj8489 Posted - 4 days ago

$OPK

User Image BigTB Posted - 4 days ago

$OPK strong close! Going higher

User Image tradertrash Posted - 5 days ago

$OPK how long have we been babysitting the commodeX newbies, sh get a stock that's a $, i call bullsh*t

User Image tradertrash Posted - 5 days ago

$OPK so many different paths they could have taken to benefit sh, they just continue the scam with the reload of commodeX, just my opinion and it's worth nothing

User Image Zerrat Posted - 5 days ago

$OPK pump And dump. good job. never ends

User Image zaza1 Posted - 5 days ago

$OPK eventually $PFE will buy opko.

User Image tradertrash Posted - 6 days ago

$OPK spending more than u make, that's a loser for sh

Analyst Ratings
HC Wainwright & Co. Buy May 8, 24
HC Wainwright & Co. Buy Apr 3, 24
Barrington Research Outperform Apr 1, 24
Piper Sandler Overweight Apr 1, 24
HC Wainwright & Co. Buy Feb 28, 24
Barrington Research Outperform Feb 28, 24
HC Wainwright & Co. Buy Aug 7, 23
Barrington Research Outperform Jun 29, 23
HC Wainwright & Co. Buy May 5, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
KRASNO RICHARD M Director Director Jan 29 Buy 0.9946 30,000 29,838 103,333 01/29/24
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Jan 19 Buy 0.9773 500,000 488,650 205,868,225 01/19/24
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Jan 18 Buy 0.9655 400,000 386,200 205,368,225 01/18/24
HSIAO JANE PH D Vice Chairman & CTO Vice Chairman & CTO Jan 17 Buy 0.95 150,000 142,500 27,999,880 01/17/24
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Jan 16 Buy 0.9543 1,000,000 954,300 204,968,225 01/16/24
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Jan 11 Buy 0.9391 511,531 480,379 203,968,225 01/11/24
Nabel Gary J. Chief Innovation Off.. Chief Innovation Officer Jan 08 Buy 0.92 216,184 198,889 107,489 01/10/24
HSIAO JANE PH D Vice Chairman & CTO Vice Chairman & CTO Jan 04 Buy 0.8726 150,010 130,899 27,849,880 01/08/24
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Jan 04 Buy 0.8964 1,500,000 1,344,600 203,456,694 01/08/24
Zerhouni Elias A. Vice Chairman and Pr.. Vice Chairman and President Jan 05 Buy 0.91 550,300 500,773 20,327,814 01/05/24
PFENNIGER RICHARD C JR Director Director Jan 05 Buy 0.94 25,000 23,500 325,000 01/05/24
Rubin Steven D Executive VP-Adminis.. Executive VP-Administration Nov 10 Buy 1.30 10,000 13,000 6,177,732 11/13/23
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Aug 17 Buy 1.76 100,000 176,000 200,956,694 08/18/23
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Aug 14 Buy 1.75 75,000 131,250 200,856,694 08/15/23
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Aug 09 Buy 1.82 100,000 182,000 200,781,694 08/10/23
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Aug 07 Buy 1.84 650,000 1,196,000 200,681,694 08/08/23
Nabel Gary J. Chief Innovation Off.. Chief Innovation Officer May 05 Buy 1.82 460,245 837,646 242,747 05/08/23
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Mar 22 Buy 1.32 200,000 264,000 200,031,694 03/23/23
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Mar 08 Buy 1.2 1,000,000 1,200,000 199,831,694 03/09/23
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Nov 22 Buy 1.49 300,000 447,000 198,831,694 11/23/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Nov 09 Buy 1.6 200,000 320,000 198,531,694 11/10/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Oct 27 Buy 1.82 100,000 182,000 198,331,694 10/28/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Oct 19 Buy 1.71 100,000 171,000 198,231,694 10/20/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Sep 26 Buy 1.8 50,000 90,000 197,756,694 09/27/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Sep 23 Buy 1.85 50,000 92,500 197,706,694 09/26/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Sep 22 Buy 1.9 50,000 95,000 197,656,694 09/23/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Sep 21 Buy 1.91 50,000 95,500 197,606,694 09/22/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Sep 20 Buy 1.94 50,000 97,000 197,556,694 09/21/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Sep 19 Buy 1.97 50,000 98,500 197,506,694 09/20/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Sep 02 Buy 2.14 100,000 214,000 197,256,694 09/06/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Aug 17 Buy 2.54 200,000 508,000 197,156,694 08/18/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Aug 05 Buy 2.28 350,000 798,000 196,956,694 08/08/22
Nabel Gary J. Chief Innovation Off.. Chief Innovation Officer Jun 22 Buy 2.49 240,000 597,600 80,000 06/24/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Jun 21 Buy 2.4 200,000 480,000 196,606,694 06/22/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Jun 16 Buy 2.32 100,000 232,000 196,406,694 06/17/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Jun 13 Buy 2.36 100,000 236,000 196,306,694 06/14/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Jun 06 Buy 2.8 100,000 280,000 196,206,694 06/07/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Jun 01 Buy 2.97 50,000 148,500 196,106,694 06/02/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman May 31 Buy 3.03 50,000 151,500 196,056,694 06/01/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman May 25 Buy 2.98 50,000 149,000 196,006,694 05/26/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman May 18 Buy 2.88 50,000 144,000 195,956,694 05/19/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman May 16 Buy 2.98 150,000 447,000 195,906,694 05/17/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman May 13 Buy 3 200,000 600,000 195,756,694 05/16/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman May 11 Buy 2.831 400,000 1,132,400 195,556,694 05/12/22
Zerhouni Elias A. Vice Chairman and Pr.. Vice Chairman and President May 09 Buy 2.7946 89,600 250,396 89,600 05/11/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman May 10 Buy 2.7839 400,000 1,113,560 195,156,694 05/11/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Mar 14 Buy 3.04 35,000 106,400 194,756,694 03/15/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Mar 11 Buy 3.13 100,000 313,000 194,721,694 03/14/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Feb 28 Buy 3.1 100,000 310,000 194,621,694 03/01/22
FROST PHILLIP MD ET AL CEO & Chairman CEO & Chairman Feb 25 Buy 3.0871 750,000 2,315,325 194,521,694 02/28/22